Business Context and Reporting Period
This Form 8-K Current Report was filed by Alphatec Holdings, Inc. on April 28, 2015. The report details corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new independent director.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased its size to 11 members.
- New Appointment: Donald A. Williams was appointed to the Board, effective April 28, 2015.
- Committee Eligibility: Mr. Williams qualifies as independent under NASDAQ rules and is eligible to serve on the Audit Committee and the Nominating, Governance and Compensation Committee.
Management Commentary and Background
Management highlighted Mr. Williams' 35-year career in public accounting, including 18 years as an Ernst & Young partner and seven years as a Partner with Grant Thornton. His expertise includes leading life sciences practices and managing IPOs, secondary offerings, and M&A transactions. He also serves on the boards of Marina Biotech, Inc. and Proove Biosciences, Inc. A press release announcing the appointment was issued on May 1, 2015.
Investor Verification Checklist
- Confirm the effective date of Donald A. Williams' appointment (April 28, 2015).
- Verify the new total size of the Board of Directors (11 members).
- Review the attached press release (Exhibit 99.1) for additional details on the appointment.
- Check subsequent filings for any changes to committee assignments for the new director.